πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8470789

Method for inducing and accelerating cells

DCPRIME B.V. Β· Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8465917

Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer Β· Granted Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8460713

Administration of cells and cellular extracts for rejuvenation

REGENICS AS Β· Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8449877

Pharmaceutically purified intact bacterial minicells

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8440460

Methods for transdifferentiating cells

The Board of Regents of the University of Texas System Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8420885

Determining the capability of a test compound to affect solid tumor stem cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8415343

Compositions and methods for inhibiting the proliferation of cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8409859

Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype

Regents of the University of Minnesota Β· Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8394764

Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nu

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8388933

Multimeric protein toxins to target cells having multiple identifying characteristics

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8389231

Assays, method and compositions that exploit a mycobacterial iron acquistion pathway in ce

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8383099

Adoptive cell therapy with young T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8361459

Treatment of stroke and other acute neural degenerative disorders using postpartum-derived

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8361733

Methods of identifying modulators of a cold-and-menthol-sensitive receptor (CMR1) and reco

The Regents of the University of California Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8357534

Isolation of human articular cartilage stem cells

University College Cardiff Consultants Limited Β· Granted Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8349609

Differentiation of human embryonic and induced pluripotent stem cells

UNIVERSITY OF CONNECTICUT Β· Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8343481

Method of preparing lung alveolar epithelial type II cells derived from embryonic stem cel

The Board of Regents of the University of Texas System Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8338173

Preparation of antigen-presenting human Ξ³Ξ΄ T cells and use in immunotherapy

University College Cardiff Consultants Limited Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8334272

Methods for nucleic acid transfer into cells

Northwestern University Β· Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318483

Postpartum cells derived from umbilical cord tissue, and methods of making and using the s

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8309070

Use of umbilical cord blood stem cells to treat ischemic event

Regents of the University of Minnesota Β· Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8277798

Use of cells containing a specific DNA molecule as cytopathic agents to inhibit the prolif

Bayerische Julius-Maximilians-UniversitΓ€t WΓΌrzburg Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8277796

Regeneration and repair of neural tissue using postpartum-derived cells

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268618

Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins

Sangamo Biosciences, Inc. Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted